Results 51 to 60 of about 319,802 (176)

تقييم رضا الأطباء و المرضى عن تطبيق المواصفة ISO 15189 في مختبرات ميديكير الطبية الفلسطينية الخاصة.

, 2023
Recently, all medical laboratories have become interested in ISO 15189, the first quality management ISO system for medical laboratories. To enhance and deliver high-quality healthcare services, it is important to understand patients’ and Physicians ...
Dina Mrwan Mohammad Abu Zayyad, دينا مروان محمد ابو زياد   +1 more
core   +1 more source

Sistema para la gestión de laboratorios clínicos conforme a la norma de calidad ISO 15189

Revista Politécnica, 2013
El presente proyecto tiene como objetivo principal desarrollar un sistema para la gestión de laboratorios clínicos conforme a la norma ISO 15189 en plataforma libre.
Javier Paez García
doaj  

The Impact of Upfront DihydroPyrimidine Dehydrogenase (DPD) Testing on the Therapeutic Management of Patients Scheduled for 5‐FU

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Purpose 5‐fluorouracil (5‐FU) is catabolized by dihydropyrimidine dehydrogenase (DPD). DPD deficiency can trigger life‐threatening toxicities, and pretesting DPD is increasingly recommended. Here, we investigated the impact of upfront DPD testing on treatment strategy, that is, whether DPD status influences physicians' choice to use 5‐FU or ...
Govind Kallee, Sébastien Salas, Gérard Milano, Florence Duffaud, Laetitia Dahan, Joseph Ciccolini   +5 more
wiley   +1 more source

Investigating the suitability of ISO 15189:2007 for medical research [PDF]

, 2013
M.Tech. (Operations Management)Accreditation allows people to make an informed decision when selecting a laboratory. It demonstrates competence, impartiality and capability.
Cohen, Sarah Shoshana
core  

Requirements for quality and competence according to EN ISO 15189 for medical virological laboratory diagnostics. A field report

, 2007
In der internationalen Norm DIN EN ISO 15189 (kurz ISO 15189) sind für medizinische Laboratorien besondere Anforderungen an die Qualität und Kompetenz festgelegt. Die ISO 15189 gilt für alle medizinischen Laboratorien.
Rabenau, Holger, Steinhorst, Andreas
core   +1 more source

Development and implementation of the Caribbean Laboratory Quality Management Systems Stepwise Improvement Process (LQMS-SIP) Towards Accreditation

African Journal of Laboratory Medicine, 2017
Background: Implementing quality management systems and accrediting laboratories in the Caribbean has been a challenge. Objectives: We report the development of a stepwise process for quality systems improvement in the Caribbean Region.
George Alemnji, Lisa Edghill, Giselle Guevara, Sacha Wallace-Sankarsingh, Rachel Albalak, Sebastien Cognat, John Nkengasong, Jean-Marc Gabastou   +7 more
doaj   +1 more source

Transcranial Magnetic Stimulation as a Translational Biomarker in Early‐Phase Anti‐Seizure Medication Development: A Randomized, Double‐Blind, Placebo‐Controlled Study in Generalized Epilepsy

Clinical Pharmacology &Therapeutics, Volume 120, Issue 3, Page 673-683, September 2026.
One‐third of epilepsy patients remain treatment‐resistant, underscoring the need for novel anti‐seizure medications (ASMs) and reliable biomarkers of central target engagement. Cortical hyperexcitability is a hallmark of epilepsy, making excitability a valuable pharmacodynamic biomarker for early‐phase drug development supporting go/no‐go decision ...
Catherine M. E. de Cuba, Titia Q. Ruijs, Annika A. de Goede, Robert J. Doll, Maria Juachon, Michel J. A. M. van Putten, Geert Jan Groeneveld, Jules A. A. C. Heuberger   +7 more
wiley   +1 more source

Clinical Utility of Trio Exome Sequencing in Rwandan Children With Autism Spectrum Disorder

Molecular Genetics &Genomic Medicine, Volume 14, Issue 9, September 2026.
Addressing the Gap: First trio‐based WES study of ASD in Rwanda, addressing African underrepresentation in global genomics. Diagnostic Yield: 12.9% yield of clinically relevant variants, consistent with global benchmarks (10%–30%). Genetic Findings: Confirmed de novo likely pathogenic variants identified in high‐impact ASD genes, including SYNGAP1 and ...
Olivier Hakizimana, Janvier Hitayezu, Jeanne P. Uyisenga, Norbert Dukuze, Marie Viviane Akimana, Laurence Mizero, Claudine Bampire, Charles Mudenge, Xavier Kanyambari Butoto, Laura Helou, Benoit Charloteaux, Jean‐Hubert Caberg, Vinciane Dideberg, Leonor Palmeira, Abdullateef Isiaka Alagbonsi, Vincent Bours, Annette Uwineza   +16 more
wiley   +1 more source

Limited Utility of a Test‐Yolk Buffer Semen Extender for Preserving Human Semen Parameters for Use in a Diagnostic Setting

Andrology, Volume 14, Issue 6, Page 1701-1711, September 2026.
ABSTRACT Background Identification of a preservation medium that accurately retains semen parameters would be advantageous for men requiring semen analysis by allowing them to produce sperm samples at home rather than on site or even facilitate ‘mail order’ semen analysis.
Alessia Schadwell, Andrew Dawkins, Tina Holton, Olivia Whiting, Peter J. I. Ellis, Sheryl T. Homa   +5 more
wiley   +1 more source

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers

British Journal of Haematology, Volume 209, Issue 3, Page 1076-1084, September 2026.
Summary The Magnolia study demonstrated that continuation of zoledronic acid (ZOL) beyond 2 years reduces the risk of progressive bone disease (PBD) in patients with multiple myeloma (MM). This follow‐up study investigated the effects of ZOL in patients achieving very good partial response (VGPR) compared to patients who did not and whether bone ...
Michael Tveden Gundesen, Annette Juul Vangsted, Carsten Helleberg, Einar Haukås, Trine Silkjær, Jonna Skov Madsen, Jon Thor Asmussen, Elena Manuela Teodorescu, Bo Amdi Jensen, Tobias Schmidt Slørdahl, Aneta Alexandra Nielsen, Dorte Aalund Olsen, Kent Søe, Hareth Nahi, Anders Waage, Niels Abildgaard, Fredrik Schjesvold, Thomas Lund   +17 more
wiley   +1 more source